Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:08 PM UTC
| NCT Number | NCT06542250 |
| Recruiting Status | Recruiting |
| Condition | B-cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 174 participants |
| Active Locations | 9 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | February 10, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06542250 is currently recruiting participants. This clinical trial study for b-cell lymphoma is actively seeking new participants at 9 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06542250 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06542250 was last updated 2 weeks ago (February 10, 2026). HelloStudys verifies this status automatically.